Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Cash Flow Reinvestment Rate
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥26.90 Million (capex CN¥26.90 Million ) from operating cash flow of CN¥133.43 Million. See cash generation quality of Zhejiang CONBA Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see how efficiently does Zhejiang CONBA Pharmaceutical Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Zhejiang CONBA Pharmaceutical Co Ltd. See 600572 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥203.16 Million | CN¥942.61 Million | CN¥147.26 Million | ▼ -37.5% |
| 2024 | 0.34x | CN¥349.14 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -9.3% |
| 2023 | 0.38x | CN¥341.77 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +13.9% |
| 2022 | 0.33x | CN¥385.99 Million | CN¥1.16 Billion | CN¥291.75 Million | ▼ -59.7% |
| 2021 | 0.83x | CN¥736.86 Million | CN¥889.94 Million | CN¥568.37 Million | ▲ +40.6% |
| 2020 | 0.59x | CN¥736.05 Million | CN¥1.25 Billion | CN¥460.40 Million | ▲ +19.8% |
| 2019 | 0.49x | CN¥454.84 Million | CN¥925.50 Million | CN¥268.79 Million | ▼ -83.6% |
| 2018 | 3.00x | CN¥1.64 Billion | CN¥545.78 Million | CN¥379.63 Million | ▲ +451.1% |
| 2017 | 0.54x | CN¥387.93 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -39.6% |
| 2016 | 0.90x | CN¥874.41 Million | CN¥969.71 Million | CN¥231.83 Million | ▼ -32.0% |
| 2015 | 1.33x | CN¥1.10 Billion | CN¥831.26 Million | CN¥286.97 Million | ▲ +90.7% |
| 2014 | 0.70x | CN¥429.23 Million | CN¥617.43 Million | CN¥429.23 Million | ▼ -65.7% |
| 2013 | 2.02x | CN¥476.32 Million | CN¥235.36 Million | CN¥476.32 Million | ▲ +107.4% |
| 2012 | 0.98x | CN¥239.76 Million | CN¥245.76 Million | CN¥239.76 Million | ▲ +38.1% |
| 2011 | 0.71x | CN¥133.09 Million | CN¥188.36 Million | CN¥133.09 Million | ▼ -21.3% |
| 2010 | 0.90x | CN¥113.07 Million | CN¥125.93 Million | CN¥113.07 Million | ▲ +158.3% |
| 2009 | 0.35x | CN¥53.32 Million | CN¥153.39 Million | CN¥53.32 Million | ▼ -57.8% |
| 2008 | 0.82x | CN¥81.12 Million | CN¥98.56 Million | CN¥81.12 Million | ▼ -19.5% |
| 2007 | 1.02x | CN¥81.83 Million | CN¥79.98 Million | CN¥81.83 Million | ▲ +10.9% |
| 2006 | 0.92x | CN¥65.67 Million | CN¥71.20 Million | CN¥65.67 Million | ▼ -6.9% |
| 2005 | 0.99x | CN¥116.57 Million | CN¥117.65 Million | CN¥116.57 Million | ▲ +1.7% |
| 2004 | 0.97x | CN¥63.81 Million | CN¥65.47 Million | CN¥63.81 Million | ▲ +61.0% |
| 2003 | 0.61x | CN¥40.34 Million | CN¥66.64 Million | CN¥40.34 Million | — |